Treatment | Page 301 of 465

Cholesterol :: New therapy to treat severely elevated cholesterol levels

Researchers at the University of Pennsylvania School of Medicine have demonstrated the potential of a new type of therapy for patients who suffer from high cholesterol levels. The findings are in the January 11 issue of the New England Journal of Medicine (NEJM). In this study, patients with homozygous familial hypercholesterolemia (FH), a high-risk condition refractory to conventional therapy, had a remarkable 51 percent reduction in low-density lipoprotein (LDL) or “bad cholesterol” levels.

Kidney Cancer :: Bayer and Onyx announce pivotal Nexavar kidney cancer study

Bayer Pharmaceuticals Corporation (NYSE: BAY) and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that the New England Journal of Medicine has published their pivotal Phase III trial demonstrating that Nexavar (sorafenib) tablets doubled median progression-free survival (PFS) in patients with advanced renal cell carcinoma (RCC), or kidney cancer.

Heart Disease :: Heart disease is the no. 1 killer of women

For decades heart disease and heart attacks have been viewed as a man?s illness. Unfortunately, nothing could be farther from the truth. Heart disease kills 500,000 American women each year. That is over 50,000 more than the number of men who die of the disease.

Heart :: Community based health care delivery system managing the total cardiovascular health

JHUSON researcher Jerilyn K. Allen, ScD, RN is heading a five-year $2.5 million study of a team- and community-based health care delivery system designed to manage the total cardiovascular health of 500 high-risk patients.

Hypertension :: Community approach to reduce hypertension

Participatory community health practices originally developed in East Baltimore, MD by JHUSON Dean and researcher Martha N. Hill, Phd, RN are now being used by another Hopkins nurse researcher, Cheryl Dennison, PhD, CRNP to address and reduce hypertension (HBP) among South African populations.

Diabetes :: Diabetes drug shows promise for preventing brain injury from radiation therapy

Researchers at Wake Forest University School of Medicine are the first to report that in animal studies, a common diabetes drug prevents the memory and learning problems that cancer patients often experience after whole-brain radiation treatments.

Water :: Water purification technique eliminates 100 percent of the microbes

Engineers have developed a system that uses a simple water purification technique that can eliminate 100 percent of the microbes in New Orleans water samples left from Hurricane Katrina. The technique makes use of specialized resins, copper and hydrogen peroxide to purify tainted water.

Heartburn :: Unexpected results in acid suppression between two OTC heartburn treatments

This release announces research that directly compared the early therapeutic response of drugs from widely used classes of heartburn medications, omeprazole magnesium, a proton pump inhibitor (PPI) and famotidine, a histamine-2 receptor antagonist (H2RAs), in an over-the-counter (OTC) setting.

Pancreatic Cancer :: Micro molecules can identify pancreatic cancer

A pattern of micro molecules can distinguish pancreatic cancer from normal and benign pancreatic tissue, new research suggests. The study examined human pancreatic tumor tissue and compared it to nearby normal tissue and control tissue for levels of microRNA (miRNA). It identified about 100 different miRNAs that are present usually at very high levels in the tumor tissue.

Arthritis :: Cartilage discovery offers arthritis hope

Scientists have revealed the intricate structure of cartilage in what they hope will provide clues to how the crippling joint disease osteoarthritis might one day be treated.